Dennis Plenker

4.5k total citations
13 papers, 214 citations indexed

About

Dennis Plenker is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Dennis Plenker has authored 13 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Dennis Plenker's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (6 papers) and Cancer Cells and Metastasis (3 papers). Dennis Plenker is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (6 papers) and Cancer Cells and Metastasis (3 papers). Dennis Plenker collaborates with scholars based in United States, Germany and Canada. Dennis Plenker's co-authors include David A. Tuveson, Hervé Tiriac, Lindsey A. Baker, Stefan Baumeister, Zhizhou Fang, Hoang Duc Nguyen, Jeffrey R. Simard, Trang Thi Phuong Phan, Daniel Rauh and Louis Scampavia and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Dennis Plenker

13 papers receiving 211 citations

Peers

Dennis Plenker

ONCOL

PRM

Vasilena Zheleva United States

Ashim Subedee United States

Marloes Zoetemelk Switzerland

Francesca Holt United Kingdom

Patrícia Izetti Brazil

Emily J. Lelliott Australia

Sascha Rahn Germany

Amnah Othman Germany

Marie Ancion Belgium

Vasilena Zheleva United States

Dennis Plenker

155 ×1.1

ONCOL

126 ×1.4

115 ×1.8

27 ×0.7

67 ×2.4

PRM

Citations per year, relative to Dennis Plenker Dennis Plenker (= 1×) peers Vasilena Zheleva

Countries citing papers authored by Dennis Plenker

Since Specialization

Citations

This map shows the geographic impact of Dennis Plenker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Plenker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Plenker more than expected).

Fields of papers citing papers by Dennis Plenker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Plenker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Plenker. The network helps show where Dennis Plenker may publish in the future.

Co-authorship network of co-authors of Dennis Plenker

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Plenker. A scholar is included among the top collaborators of Dennis Plenker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Plenker. Dennis Plenker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Ubhi, Tajinder, Olga Zaslaver, Andrew T. Quaile, et al.. (2024). Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells. Nature Cancer. 5(6). 895–915. 12 indexed citations

Lorenz, Carina, Maria Cartolano, Dennis Plenker, et al.. (2023). Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer. Cancer Research. 83(15). 2471–2479. 7 indexed citations

Fernández-Vega, Virneliz, Shurong Hou, Dennis Plenker, et al.. (2022). Lead identification using 3D models of pancreatic cancer. SLAS DISCOVERY. 27(3). 159–166. 21 indexed citations

Knox, Jennifer J., Elizabeth M. Jaffee, Grainne M. O’Kane, et al.. (2022). PASS-01: Pancreatic adenocarcinoma signature stratification for treatment–01.. Journal of Clinical Oncology. 40(4_suppl). TPS635–TPS635. 14 indexed citations

Lyons, Scott K., Dennis Plenker, & Lloyd C. Trotman. (2021). Advances in preclinical evaluation of experimental antibody-drug conjugates. Cancer Drug Resistance. 4. 745–754. 6 indexed citations

Gao, Chong, Ying Liu, Ben Staal, et al.. (2020). Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. Clinical Cancer Research. 27(1). 226–236. 17 indexed citations

LaComb, Joseph F., Dennis Plenker, Hervé Tiriac, et al.. (2020). Single-Pass vs 2-Pass Endoscopic Ultrasound-Guided Fine-Needle Biopsy Sample Collection for Creation of Pancreatic Adenocarcinoma Organoids. Clinical Gastroenterology and Hepatology. 19(4). 845–847. 24 indexed citations

Tiriac, Hervé, Dennis Plenker, Lindsey A. Baker, & David A. Tuveson. (2019). Organoid models for translational pancreatic cancer research. Current Opinion in Genetics & Development. 54. 7–11. 55 indexed citations

Tiriac, Hervé, Pascal Belleau, Dannielle D. Engle, et al.. (2019). Abstract C57: Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Research. 79(24_Supplement). C57–C57. 6 indexed citations

10.

Sugarman, Ryan, et al.. (2019). Pharmacokinetics and pharmacodynamics of new drugs for pancreatic cancer. Expert Opinion on Drug Metabolism & Toxicology. 15(7). 541–552. 13 indexed citations

11.

Michels, Sebastian, Matthias Scheffler, Dennis Plenker, et al.. (2018). Loss of G2032R Resistance Mutation Upon Chemotherapy Treatment Enables Successful Crizotinib Rechallenge in a Patient With ROS1-Rearranged NSCLC. JCO Precision Oncology. 2(2). 1–6. 3 indexed citations

12.

Schöttle, Jakob, Sampurna Chatterjee, Alexandra Florin, et al.. (2015). Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer. Oncotarget. 6(36). 38458–38468. 16 indexed citations

13.

Fang, Zhizhou, Jeffrey R. Simard, Dennis Plenker, et al.. (2014). Discovery of Inter-Domain Stabilizers—A Novel Assay System for Allosteric Akt Inhibitors. ACS Chemical Biology. 10(1). 279–288. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact